LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy
Yajuan Yan,1,* Ting Duan,1,* Xiaonan Xue,1,* Xiaojuan Yang,2 Miao Liu,2 Bin Ma,3,4 Xiangguo Duan,2 Chunxia Su1 1Department of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 2Department of Inspection, Ningxia Medical University, Yinchuan, Ningxia,...
Saved in:
Main Authors: | Yan Y, Duan T, Xue X, Yang X, Liu M, Ma B, Duan X, Su C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/lbp-cd155-liposome-nanovaccine-efficiently-resist-colorectal-cancer-an-peer-reviewed-fulltext-article-IJN |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent advances of nanovaccines on cancer theranostics
by: Xiaobing Yuan, et al.
Published: (2025-02-01) -
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01) -
Exploring phytochemicals and their pharmacological applications from ethnomedicinal plants: A focus on Lycium barbarum, Solanacea
by: Baiken Baimakhanova, et al.
Published: (2025-01-01) -
CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
by: Rongpu Liang, et al.
Published: (2025-02-01) -
Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
by: Lu Y, et al.
Published: (2025-01-01)